Skip to main content
Loading ResearchHub…
References for A phase 1 trial of CD123-directed chimeric antigen receptor T-cell therapy in adults with relapsed/refractory acute myeloid leukemia or blastic plasmacytoid dendritic cell neoplasm | ResearchHub - ResearchHub